Inoculation - through skin abrasions/mucous membranes/transfusions/injections/transplants
Congenital - from mother to foetus
Stopping a virus:
Host defence mechanisms
Humoral
Cell-mediated
Antiviral agents
Inhibition of nucleic acid synthesis
Inhibition of viral proteins
Antiviral agents are still underdeveloped in comparison to antibiotics.
Balance of host defence mechanisms:
Role of cytokines
The activation of host cells such as lymphocytes
Lymphocytes such as T or B cells and Natural Killer cells
Immuno-stimulation can be achieved by:
Administration of human immune globulin
Administration of immuno-stimulant drugs
This is usually done by vaccination
Antivirals in dental practice are nucleoside analogues - interfere with replication of viral nucleic acid - therefore more effective the earlier they are prescribed.
Antiherpetic agents are predominantly nuceloside analogues - example: aciclovir - an analogue of the purine nucleoside guanosine. These are incorporated into DNA - why they can induce toxicity if used inappropriately.
How acyclovir (an antiherpetic agent - aka a nucleoside analogue) works:
Transformed by phosphorylation into active state by viral enzymes - so the virus helps to activate the therapeutic agent
Greater affinity for viral than host enzymes - therefore less toxic - important; one of the problems with antiviral agents is that as well as affecting the viral DNA, they can also affect host DNA, so there's a limitation on the dose that can be used
Incorporates into viral DNA
Inhibits viral DNA synthesis
In the early stages, when there's more replication going on, it's going to be more effective
Pharmacokinetics of acyclovir (antiherpetic agent - aka a nucleoside analogue):
Aciclovir half-life is 2.5 hours (short)
Crosses the blood-brain barrier - given systemically
Excreted by the kidneys
Resistance is rare
Administration: may be prescribed topically (ointment - by dentist) or intravenously (in hospital)
Unwanted effects of acyclovir (antiherpetic agent - aka a nucleoside analogue):
Nausea and headaches
Transient burning sensation on application
Idoxuridine:
A thymidine analogue
Phosphorylated in cells and is incorporated into cellular and viral DNA
Unlike aciclovir it doesn't block DNA synthesis
Mainly used against DNA viruses and is too toxic for systemic use - can be used topically though
Zidovudine (AZT):
A thymidine analogue
Cytopathic against HIV-1
Mode of action:
Inhibits viral RNA-dependent DNA polymerase
Prevents further nucleotides from being incorporated into a growing strand of DNA
Action can be enhanced by aciclovir and interferon
Administration: orally or by continuous intravenous infusion
Zidovudine (AZT):
Pharmacokinetics:
Rapidly absorbed from GIT
Peak plasma concentration after 30-90 minutes
Metabolised in the liver and excreted via kidneys
Unwanted effects:
Anaemia
Granulocytopaenia
Regular blood count every 2 weeks
Main use = treatment of HIV and AIDS patients who are symptomatic
Reverse transcriptase inhibitors:
An RNA-dependent DNA polymerase inhibitor
They are nucleoside analogues - some of the newer drugs e.g. Nevirapine are non-nucleosides
Non-nucleoside analogues are used in the treatment of AIDS - eg nevirapine and delavirdine
Other antiviral agents:
Interferons - a group of cytokines
3 main types: Alpha/Beta/Gamma
Glycoproteins produced by the body in response to a viral infection
Enhance the cytotoxic capacity of T-lymphocytes
Prions:
Not bacteria or virus but are infective agents
Contain no genetic material and are pure proteins
Can produce configurational changes in host protein
Prion diseases:
BSE - Bovine Spongiform Encephalitis (cattle)
Creutzfeldt-Jakob disease
Not possible to sterilise instruments - disposable used